Experience dependent: Hyper Recruitment Solutions (HRS): Your duties as the Bioinformatician will be varied however the key duties and responsibilities are as follows: 1. As a Bioinformatician you will analysing NGS... London

Notice NOT-OD-19-150 from the NIH Guide for Grants and Contracts

F. Hoffmann-La Roche AG: Roche has been taken a strategic effort across functions and sites to improve data quality and to make data FAIR (findable, accessible, interop Switzerland (CH)

Funding Opportunity RFA-MD-20-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from eligible institutions of higher education for specialized center grants to support multidisciplinary research, research capacity building, and community-engaged research activities focused on understanding and reducing or eliminating environmental health disparities, defined as inequities in population health mediated by disproportionate adverse exposures associated with the physical, chemical, social and built environments.

Competitive with benefits, subject to skills and experience: The Francis Crick Institute: We are looking for a suitable candidate with a graduate degree, mathematical experience and good communication skills. London (Central), London (Greater)

Funding Opportunity RFA-CA-19-059 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is intended to continue support for the Pediatric Brain Tumor Consortium (PBTC). This Limited-Competition FOA solicits a single application from the current PBTC awardee. The PBTC was conceived as a dedicated clinical trials organization able to translate innovative therapies from the laboratory to early phase clinical testing so that treatment for primary brain tumors in children can be improved. The importance of the PBTC is highlighted by the continuing high mortality rate among some common brain tumors occurring in children [e.g., diffuse intrinsic pontine gliomas (DIPG), malignant supratentorial gliomas, and biologically high-risk medulloblastomas and ependymomas] and the functional impediments apparent in a large proportion of children surviving current therapies. The PBTC is designed to fill a unique niche in the NIH pediatric brain tumor research portfolio through its ability to translate multiple innovative therapies from the laboratory to early phase clinical testing.

Notice NOT-NR-19-011 from the NIH Guide for Grants and Contracts

Salary Depends on Experience: Dana-Farber Cancer Institute: Dana-Farber seeks a Research Scientist with 2 years of post-PhD collaborative experience in medical research and statistical expertise. Boston, Massachusetts (US)

Notice NOT-HD-19-032 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Senior Cancer Analyst - Genomics England London Genomics England applies state of the art approaches to whole genome sequences for processing, analys London, England

Negotiable: Paramount Recruitment: Senior Bioinformatics Analyst London To build on the success of the 100,000 Genomes Project, the Government tasked NHS England with support from Geno London, England

Notice NOT-HD-19-031 from the NIH Guide for Grants and Contracts

Notice NOT-GM-19-060 from the NIH Guide for Grants and Contracts

Notice NOT-CA-19-071 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: Bioinformatician Location: EMBL- Cambridge, Cambridgeshire, England

Funding Opportunity RFA-AA-20-003 from the NIH Guide for Grants and Contracts. The objective of the NADIA consortium is to investigate persistent changes in complex brain function-behavior relationships following adolescent alcohol exposure. The Consortium model provides a mechanism for fostering interdisciplinary cooperation with a group of established investigators conducting exceptional alcohol research at different institutions. The purpose of this initiative is to continue support for collaborative research projects focusing on research efforts across different research institutions investigating the consequences of repeated adolescent alcohol exposure on brain maturation and adult abilities. Because NIAAA is interested in supporting experimental studies on the effects of controlled alcohol doses and exposure periods, this initiative is limited to animal studies only. T

Funding Opportunity RFA-AA-20-004 from the NIH Guide for Grants and Contracts. The objective of the NADIA consortium is to investigate persistent changes in complex brain function-behavior relationships following adolescent alcohol exposure. The Consortium model provides a mechanism for fostering interdisciplinary cooperation with a group of established investigators conducting exceptional alcohol research at different institutions. The purpose of this initiative is to continue support for collaborative research projects focusing on research efforts across different research institutions investigating the consequences of repeated adolescent alcohol exposure on brain maturation and adult abilities. Because NIAAA is interested in supporting experimental studies on the effects of controlled alcohol doses and exposure periods, this initiative is limited to animal studies only.

Funding Opportunity RFA-AA-20-005 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism intends to renew an initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for Research Resources -Cooperative Agreements (U24) to provide technical and scientific support to the research projects (U01) as part of the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA). The objective of the NADIA consortium is to investigate persistent changes in complex brain function-behavior relationships following adolescent alcohol exposure.

Notice NOT-GM-19-059 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-NS-20-003 from the NIH Guide for Grants and Contracts. This FOA solicits Research Education Grant (R25) applications to develop and implement a short course focused on (1) steps required for successful medical device development and translation, (2) common technical and strategic challenges, and (3) best-practices and resources for each stage in the process. Applicants may choose to include an extended mentorship plan if they see fit. The short course should address a broad audience, including senior post-doctoral fellows, independent academic researchers, clinician scientists, and small business entrepreneurs interested in developing and translating medical devices to diagnose or treat a nervous system disorder.